Detalhe da pesquisa
1.
Phase I study and preclinical efficacy evaluation of the mTOR inhibitor sirolimus plus gemcitabine in patients with advanced solid tumours.
Br J Cancer
; 111(5): 858-65, 2014 Aug 26.
Artigo
Inglês
| MEDLINE | ID: mdl-25003665